Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Agilon Health revenue beats but earnings miss drives stock down

EditorNatashya Angelica
Published 02/27/2024, 05:02 PM
Updated 02/27/2024, 05:02 PM
© Reuters.

AUSTIN - Agilon Health Inc. (NYSE: AGL) reported a significant increase in its fourth quarter revenue, which soared 72% to $1.06 billion compared to the same quarter last year, outpacing the consensus estimate of $1.02 billion.

Despite the impressive revenue growth, the company's stock fell nearly 7% in aftermarket trading due to an earnings miss. The adjusted earnings per share (EPS) for the quarter was reported at -$0.41, which was $0.17 short of the analyst estimate of -$0.24.

The company's Medicare Advantage membership saw a substantial increase of 68% to 388,400, contributing to the revenue growth. However, the fourth quarter was impacted by higher medical costs, which the company attributes to macroeconomic dynamics. These increased costs have led to a revised guidance for 2024, with Agilon Health projecting continued trends of elevated medical expenses.

For the first quarter of 2024, Agilon Health expects revenue to be between $1.605 billion and $1.63 billion, slightly above the consensus estimate of $1.596 billion. The full-year 2024 revenue guidance is forecasted to range from $6.35 billion to $6.42 billion, with the midpoint of this range falling just below the consensus estimate of $6.381 billion.

Steve Sell, the chief executive officer of Agilon Health, commented on the results, stating, "While near-term dynamics are negatively affecting our financial results, demand for our platform and the fundamental drivers of our business remain strong as we continue to deliver significant value to patients, payors, and our PCP partners."

The company's action plan to improve performance includes expanding support for new primary care physicians, refining payor partnerships, and enhancing data analytics. Agilon Health anticipates adding at least 60,000 Medicare Advantage members across 5 physician groups for the Class of 2025, indicating a measured approach to growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors reacted negatively to the earnings miss, with the stock experiencing a significant drop. The company's performance plan and positive revenue guidance for the coming quarters suggest efforts to address the challenges and capitalize on the strong demand for its platform.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.